Importantly, APOE4 is not only associated with the risk for DLB, PDD and cognitive impairment in PD [29, 35, 61], but also the increased severity of synucleinopathies independent of amyloid pathology in AD [11]. This evidence concerns the gene APOE and amyloidosis.